Benefit of Methrotrexate in Psoriasis Will Show Up Early, University of Geneva Study

Published: Oct 14, 2009

Bookmark and Share

MedPage Today -- BERLIN -- A suboptimal response to methotrexate at 12 weeks identified psoriasis patients who were unlikely to benefit from continued therapy at higher doses, a retrospective analysis of clinical trial data showed.

Back to news